First-in-human data for the trispecific antibody “suggest a paradigm shift” for the relapsed/refractory multiple myeloma ...

Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.

A single dose of the long-acting antibody nirsevimab to infants can halve hospitalizations for bronchiolitis.

The first-in-class antibody-drug conjugate (ADC) pivekimab sunirine (PVEK) demonstrated promising efficacy and high response ...

JNJ-79635322 shows favorable responses and manageable safety in BCMA/GPRC5D-naïve patients with relapsed/refractory multiple ...

Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of ...

Due to their extraordinary specificity and pharmacokinetic (PK) behavior, human immunoglobulin gamma monoclonal antibodies (hIgG mAbs) are a most promising biological therapy for treating an ...

Appropriate dilutions of standard or experimental sample were added to ELISA plates coated with huTRAIL (M180) monoclonal antibody, incubated for 1 h at room temperature, washed thoroughly with ...

Corticosteroid therapy induces clinical, laboratory and histological improvements in 80% of patients with autoimmune hepatitis. Prednisone, alone or at a lower dose in combination with ...